Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6482111 | Vaccine | 2014 | 7 Pages |
Abstract
Seroprevalence is lower than required levels for poliovirus interruption in the KMA. Persistence of immunity gaps in the 36-47Â months group is a big concern. Since higher number of vaccine doses is associated with higher seroprevalence, it implies that failure-to-vaccinate and not vaccine failure accounts for the suboptimal seroprevalence. Intensified efforts are necessary to administer polio vaccines to all target children and surpass the threshold levels for herd immunity.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Zubairu Iliyasu, Eric Nwaze, Harish Verma, Asani O. Mustapha, Goitom Weldegebriel, Alex Gasasira, Kathleen A. Wannemuehler, Mark A. Pallansch, Auwalu U. Gajida, Muhammad Pate, Roland W. Sutter,